ID   EqT8888
AC   CVCL_7191
DR   Wikidata; Q54832410
RX   PubMed=1604800;
RX   PubMed=17686531;
RX   PubMed=29844485;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Arabian; VBO=VBO_0000905.
DI   NCIt; C134778; Horse lymphoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
RX   PubMed=1604800; DOI=10.1016/0165-2427(92)90066-Y;
RA   Swiderski, Cyprianna Ellen
RA   Truax, Robert Eugene
RA   Pourciau, Susan S.
RA   Folsom, Robert William
RA   Horohov, David Walter
RT   "Induction of lymphokine-activated killer cells of equine origin:
RT   specificity for equine target cells.";
RL   Vet. Immunol. Immunopathol. 32:25-36(1992).
//
RX   PubMed=29844485; DOI=10.1038/s41598-018-26512-3; PMCID=PMC5974405;
RA   Evans, Elizabeth
RA   Paillot, Romain
RA   Lopez-Alvarez, Maria Rocio
RT   "A comprehensive analysis of e-CAS cell line reveals they are mouse
RT   macrophages.";
RL   Sci. Rep. 8:8237.1-8237.6(2018).
//
RX   PubMed=17686531; DOI=10.1016/j.vetimm.2007.06.027;
RA   Steinbach, Falko
RA   Saunders, Kelly
RA   Kydd, Julia H.
RA   Ibrahim, Sherif
RT   "Further characterization of cross-reactive anti-human leukocyte mAbs
RT   by use of equine leukocyte cell lines EqT8888 and eCAS.";
RL   Vet. Immunol. Immunopathol. 119:100-105(2007).
//